Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 12 July 2006. doi:10.1136/jcp.2006.038752
Journal of Clinical Pathology 2007;60:167-172
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL

Joost C van Galen1,*, Jettie J F Muris1,*, Joost J Oudejans1, Wim Vos1, Cindy P E Giroth1, Gert J Ossenkoppele2, Arie P Otte3, Frank M Raaphorst1,4, Chris J L M Meijer1

1 Departments of Pathology, VU Medical Center, Amsterdam, The Netherlands
2 Departments of Haematology, VU Medical Center, Amsterdam, The Netherlands
3 Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
4 Crucell Holland BV,Leiden, The Netherlands

Correspondence to:
Dr J J Oudejans
Department of Clinical Pathology, VU Medical Center, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands; jj.oudejans{at}vumc.nl

Background: : Clinical outcome in patients with diffuse large B cell lymphomas (DLBCL) is highly variable and poorly predictable. Microarray studies showed that patients with DLBCL with a germinal centre B cell-like (GCB) phenotype have a better prognosis than those with an activated B cell-like (ABC) phenotype. The BMI1 proto-oncogene was identified as one of the genes present in the signature of the ABC type of DLBCL, associated with a poor prognosis.

Objectives: : (1) To investigate, in primary nodal DLBCL, the expression of BMI1 and its association with clinical outcome and DLBCL signature; (2) to look for an association between BMI1 expression and the expression of its putative downstream targets p14ARF and p16INK4a.

Results: : BMI1 expression was found to be associated with poor clinical outcome, but not clearly with an ABC-like phenotype of DLBCL. Expression of BMI1 was frequently, but not always, related to low levels of expression of p14ARF and p16INK4a.

Conclusion: : Expression of BMI1 is associated with an unfavourable clinical outcome of primary nodal DLBCL.

Abbreviations: ABC, activated B cell; DLBCL, diffuse large B cell lymphomas; GCB, germinal centre B cells


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs